Comparison of Regulatory T-Cell Subpopulations in Antithymocytic Globulin Versus Post-Transplant Cyclophosphamide for Preventing Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation—A Retrospective Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26062521 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Bu-Yeon Heo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea. Hauptthemen laut MEDLINE: Graft vs Host Disease, T-Lymphocytes, Regulatory, Hematopoietic Stem Cell Transplantation, Cyclophosphamide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, research fund of Chungnam National University.
Abstract (Originalsprache)
Antithymocytic globulin (ATG) and post-transplant cyclophosphamide (PTCy) are frequently used regimens for graft-versus-host disease (GVHD) prophylaxis. However, there is a lack of data about the difference in regulatory T-cell (Treg) subpopulations between these two regimens. Peripheral blood samples were collected on day +21 following allogeneic hematopoietic stem cell transplantation (Allo-HSCT), and the Treg subpopulations were analyzed using flow cytometry. The Treg populations were categorized into three distinct subgroups: naïve, effector, and non-suppressive. And we compared overall survival (OS), the cumulative incidence of acute and chronic GVHD, and the relapse rate between the ATG and PTCy groups. We enrolled 45 patients (28 in ATG, 17 in PTCy) in total. In the ATG group, 16 and 12 patients underwent human leukocyte antigen (HLA) matched-sibling donor and unrelated donor HSCT, respectively. In the PTCy group, 12 patients underwent haplo-identical HSCT, and 5 patients underwent HLA-matched unrelated donor HSCT. The cumulative incidence of Grade 2–4 acute GVHD was 18.3% in the ATG group compared to 38.1% in the PTCy group (p = 0.13), while severe chronic GVHD occurred in 19.4% of ATG patients and 41.7% of PTCy patients (p = 0.343). And OS and the relapse rate were not statistically different between the two groups. The conventional CD25+FOXP3+Treg count of CD4 + T cells was higher in the PTCy group than in the ATG group (p = 0.0020). The effector Treg subset was significantly higher in the PTCy group than in the ATG group (p = 0.0412). And the effector Treg cell count had an inverse correlation with the severity of acute GVHD (p = 0.0007). Effector Tregs may be used as a biomarker to predict the severity of acute GVHD after allo-HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Science, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
- Brain Korea 21 FOUR Project for Medical Science, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
- Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 34134, Republic of Korea.
- Translational Immunology Institute, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
ORCID-Profile: Jeong Suk Koh, Su-Young Choi, Thi Thuy Duong Pham, Yunseon Jang, Deog-Yeon Jo, Jaeyul Kwon, Ik-Chan Song
Förderung
- National Research Foundation of Korea
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare
- research fund of Chungnam National University
- Korea Health Industry Development Institute (KHIDI)
- Chungnam National University
Zitieren
APA
Heo, B. Y., Koh, J. S., Choi, S. Y., Pham, T. T. D., Lee, S. W., Park, J. H., Jang, Y., Lee, M. W., Lee, S. B., Seo, W., Jo, D. Y., Kwon, J., & Song, I. C. (2025). Comparison of Regulatory T-Cell Subpopulations in Antithymocytic Globulin Versus Post-Transplant Cyclophosphamide for Preventing Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation—A Retrospective Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062521
Vancouver
Heo BY, Koh JS, Choi SY, Pham TTD, Lee SW, Park JH, et al. Comparison of Regulatory T-Cell Subpopulations in Antithymocytic Globulin Versus Post-Transplant Cyclophosphamide for Preventing Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation—A Retrospective Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062521
BibTeX
@article{Heo2025,
author = {Heo, Bu-Yeon and Koh, Jeong Suk and Choi, Su-Young and Pham, Thi Thuy Duong and Lee, Sang-Woo and Park, Jung-Hyun and Jang, Yunseon and Lee, Myung-Won and Lee, Seul-Bi and Seo, Wonhyoung and Jo, Deog-Yeon and Kwon, Jaeyul and Song, Ik-Chan},
title = {Comparison of Regulatory T-Cell Subpopulations in Antithymocytic Globulin Versus Post-Transplant Cyclophosphamide for Preventing Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation—A Retrospective Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26062521}
}
EUVIMED